Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best Time Take MK-677 Morning Night: Protocol Comparison

Morning (fasted, upon waking) Amplifies daytime basal secretion; nocturnal pulse unaffected by peak drug activity Hunger surge occurs during waking hours when food intake is planned Minimal sleep disruption; no REM rebound or grogginess 70–80% sustain use beyo

This comparison does not assign a generated winner or score.

  • Morning (fasted, upon waking)
  • Amplifies daytime basal secretion; nocturnal pulse unaffected by peak drug activity
  • Hunger surge occurs during waking hours when food intake is planned
  • Minimal sleep disruption; no REM rebound or grogginess
  • 70–80% sustain use beyond 12 weeks
  • Best for long-term protocols prioritizing quality of life and adherence
  • Evening (60–90 min before bed)
  • Peak secretagogue activity aligns with natural nocturnal GH pulse during slow-wave sleep
  • Hunger surge hits late evening when willpower is low and unplanned eating is common
  • Increased sleep latency, vivid dreams, morning lethargy reported in 40–60% of users
  • 45–55% sustain use beyond 12 weeks
  • Theoretically optimal for GH output; practically difficult to sustain
  • Split Dosing (half morning, half evening)
  • Maintains elevated baseline throughout 24-hour period without single large peak
  • Distributes appetite stimulation across two smaller windows
  • Moderate impact. Less severe than single evening dose but not eliminated
  • 55–65% adherence beyond 12 weeks
  • Viable compromise for users who tolerate evening dosing but want to reduce side effect severity
More references

Related material